ArticleCancer science2025

Efficacy and Safety of T-DXd in HER2+ and Low/Zero Metastatic BCBM: A Retrospective Multicenter Real-World Study.

Qingru Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.